Xconomy Texas — San Antonio — Martin Landon, a long-time San Antonio life sciences executive, has left the chief executive role at medical device maker CeloNova Biosciences a year after selling a portion of the business to Boston Scientific for $70 million. Landon has taken a new job as the CEO of nonprofit BioBridge Global.
San Antonio-based BioBridge runs a few different organizations that focus on regenerative medicine treatments and research, including the South Texas Blood & Tissue Center, QualTex Laboratories, and GenCure. The groups provide products and services such as blood resource management and collecting donated umbilical cord blood.
San Antonio-based BioBridge runs a few different organizations that focus on regenerative medicine treatments and research, including the South Texas Blood & Tissue Center, QualTex Laboratories, and GenCure. The groups provide products and services such as blood resource management and collecting donated umbilical cord blood.
